- CBAK Energy signed an investment agreement with the Nanjing Gaochun Economic Development Zone for a project adding 12 GWh of annual cell capacity, focused on large cylindrical sodium-ion cells.
- The project is contingent on securing financing and would only break ground in the second half of 2027; none of the projected RMB4.8–5.0 billion in annual revenue represents contracted sales.
- The new lines will be designed to run either sodium-ion or lithium-ion chemistry, with the final choice driven by customer demand and market conditions.
Sodium-ion batteries spent years as the technology that would always arrive “next.” Lithium was too expensive, the story went, and then lithium prices collapsed, and the urgency evaporated. But behind the headline price swings, sodium-ion kept maturing quietly. Whether 2026 becomes the year it moves from pilot projects to factory floors depends on announcements like this one, and on how many of their caveats survive contact with financing markets.
The latest signal comes from CBAK Energy Technology Limited (NASDAQ: CBAT), which announced on September 24 that it has signed an investment agreement with the Nanjing Gaochun Economic Development Zone for the research, development, and manufacture of large cylindrical sodium-ion battery cells and integrated battery systems in Nanjing, Jiangsu Province. The project would add 12 gigawatt-hours of annual cell production capacity, with would being the operative word. CBAK plans to advance the project in the second half of 2027, explicitly subject to securing financing, with development proceeding in phases based on financing availability, customer demand, and project readiness. None of the revenue estimates (RMB4.8 to 5.0 billion annually at full capacity, priced at current lithium-ion cell market rates) represents contracted sales, and the company says so plainly in the release’s forward-looking statements section.
The plan, with caveats up front
Because the contingencies are the story as much as the capacity figure, they belong here rather than in a closing paragraph. Battery factory announcements have a well-documented habit of slipping between agreement-signing and ground-breaking, and CBAK’s is no exception: financing unsecured, timeline set for H2 2027 at the earliest, revenue projections explicitly non-contracted. What is concrete today is the agreement itself and the dual-chemistry line design. Everything else is a plan awaiting capital.

The more interesting feature is the dual-chemistry design. The production lines will be built to manufacture large cylindrical cells in either sodium-ion or lithium-ion chemistry, and CBAK will decide which to run based on market conditions and customer demand. That hedge says something honest about where sodium-ion stands: promising enough to build for, uncertain enough not to bet the line on. An independent read of the hedge: it protects CBAK if sodium-ion pricing disappoints, but it also means the “12 GWh sodium-ion plant” headline could in practice become a 12 GWh lithium-ion plant with sodium-ion optionality. Investors should watch which chemistry the lines actually run rather than what the agreement calls them.
| Metric | 6 GWh expansion (existing site) | 12 GWh project (new agreement) |
|---|---|---|
| Target completion | Year-end 2026 | H2 2027 at the earliest |
| Capacity effect | 4.5 → 10.5 GWh | +12 GWh of cell capacity |
| Chemistry | Lithium-ion (Model 32140 / 60150) | Dual-chemistry: sodium-ion or lithium-ion |
| Financing status | Underway | Contingent on securing financing |
| Estimated annual revenue (full capacity) | RMB2.4–2.7 billion | RMB4.8–5.0 billion |
| Revenue basis | All output sold, non-contracted | All output sold, priced at Li-ion rates, non-contracted |
Sodium-ion’s pitch: abundance vs price
Sodium-ion’s pitch has always been resource economics. Sodium is roughly a thousand times more abundant than lithium in the Earth’s crust, and it can be extracted from seawater or common salt deposits, no lithium brine operations, no cobalt, no nickel in many formulations. For stationary energy storage, where weight matters less than cost and longevity, the chemistry is a natural fit.
The pricing picture, however, is more contested than the abundance story. Independent assessments in 2026 generally describe sodium-ion cells as currently costing roughly the same as, or somewhat more than, LFP cells. CATL has claimed volume pricing for its Naxtra sodium-ion cells as low as $19/kWh, a figure that should be treated skeptically absent independent confirmation, given that it would undercut even the cheapest LFP by two-thirds.
The honest summary: sodium-ion has closed most of the cost gap with LFP but has not yet won on price. Its investment case rests on supply-chain optionality and price stability (immunity to lithium’s violent cycles) rather than on being the cheapest cell today. That is a real advantage, but it is a different claim than “cheaper batteries,” and CBAK’s revenue projections (priced at lithium-ion market rates, note) implicitly concede the point.
The momentum in 2026 is tangible even without a price victory. CBAK’s own release notes that customer testing and qualification of its sodium-ion cells is underway, though the company has not publicly named the testing customers, which limits how much weight the claim can carry. Earlier this year, Australia connected its first grid-connected sodium-sulfur battery, a cousin technology also built on abundant sodium, to the National Electricity Market. CATL’s Naxtra cells have reached 175 Wh/kg in commercial production, within striking distance of LFP’s 160–180 Wh/kg. The pattern is less “graduation day” than steady industrialization: each quarter adds a deployment, a customer trial, or a capacity commitment that would have been news on its own two years ago.
The lithium problem it doesn’t have
The deeper story is about supply-chain optionality. Lithium prices have been violently cyclical: the 2022 spike above US$70,000 per tonne was followed by a collapse that wiped out most of the premium. Every swing reminds automakers and storage developers that a battery industry built on one metal is a battery industry exposed to one metal’s politics and geology. Sodium-ion doesn’t need to beat lithium-ion on energy density to matter; it needs to be cheap, safe, durable, and available from everywhere. At stationary storage scales (the segment growing fastest alongside solar and wind), that combination is already commercially interesting, even at price parity rather than a discount.

CBAK’s own parallel 6 GWh expansion underscores the point. Targeted for completion by year-end 2026, it will lift the existing Nanjing facility from 4.5 GWh to 10.5 GWh of annual cell capacity, driven by demand for the company’s Model 32140 and Model 60150 large cylindrical lithium-ion cells. CBAK is not pivoting away from lithium; it’s adding a second lane. At full capacity with all output sold, the 6 GWh expansion alone could generate an estimated RMB2.4–2.7 billion (US$356–400 million) in annual revenue, which suggests the company’s customers are buying whatever high-power cylindrical cells it can make right now, in whichever chemistry.
12 GWh vs a 9 GWh global market
The scale claims deserve a reality check against the market they are entering. Total global sodium-ion shipments reached roughly 9 GWh in 2025, meaning CBAK’s planned 12 GWh would exceed the entire 2025 world market by a third, from a single project that has not yet secured financing. For comparison, CATL’s landmark 60 GWh supply deal with HyperStrong, the largest sodium-ion contract to date, is five times the CBAK project, from a company that already ships at scale. The framing matters: CBAK is not riding a wave of sodium-ion demand so much as betting that the wave arrives before 2027, and building a dual-chemistry hedge in case it doesn’t. For the chemistry landscape, see our battery chemistries explainer; for the cost backdrop, our 2026 grid-scale battery cost breakdown and how grid batteries work.
Financing, chemistry selection, and cost at scale
Three questions will decide how much this announcement is worth. First, financing: the 12 GWh project only moves in the second half of 2027 if the money is secured, and battery factory projects have a well-documented habit of slipping from agreement-signing to ground-breaking. Second, chemistry selection: which lines end up running sodium-ion will be the real tell on where CBAK sees customer pull, and whether the “sodium-ion plant” framing survives contact with market reality. Third, cost at scale: sodium-ion’s remaining skeptics aren’t arguing about abundance anymore; they’re asking for field data and a price point that beats LFP rather than matching it.
If CBAK delivers even part of this plan, it joins a growing club of manufacturers treating sodium-ion not as a lithium hedge but as a product line. The industry spent a decade asking whether sodium-ion could work. The question it’s starting to ask instead: at what price point does it win stationary storage outright? On current evidence, the answer is “not yet,” but the gap is measured in single dollars per kilowatt-hour now, not orders of magnitude.





